In addition to inflammation, TLR9 activation on HSCs results in HSC activation; a lack of TLR9 greatly reduces HSC activation and liver fibrosis.168 Recently, it has been demonstrated that serum mtDNA levels are elevated in patients with NASH and correlated with the degree of liver fibrosis. The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatohepatitis.